Cargando…
Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models
Age-related macular degeneration (AMD) is a major leading cause of irreversible visual impairment in the world with limited therapeutic interventions. Histological, biochemical, genetic, and epidemiological studies strongly implicate dysregulated lipid metabolism in the retinal pigmented epithelium...
Autores principales: | Landowski, Michael, Bowes Rickman, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817708/ https://www.ncbi.nlm.nih.gov/pubmed/34788573 http://dx.doi.org/10.1089/jop.2021.0067 |
Ejemplares similares
-
Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice
por: Landowski, Michael, et al.
Publicado: (2019) -
Regulation of age-related macular degeneration-like pathology by complement factor H
por: Toomey, Christopher B., et al.
Publicado: (2015) -
Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration
por: Toomey, Christopher B., et al.
Publicado: (2018) -
Targeting Tissue Lipids in Age-related Macular Degeneration
por: Apte, Rajendra S.
Publicado: (2016) -
Lipids, Lipoproteins, and Age-Related Macular Degeneration
por: Ebrahimi, Katayoon B., et al.
Publicado: (2011)